Kiromic BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KRBP and buy or sell other stocks, ETFs, and their options commission-free!About KRBP
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers.
CEOPietro Bersani, CPA
CEOPietro Bersani, CPA
Employees44
Employees44
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2006
Founded2006
Employees44
Employees44
KRBP Key Statistics
Market cap68.23K
Market cap68.23K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume8.12K
Average volume8.12K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.40
52 Week high$2.40
52 Week low$0.03
52 Week low$0.03
People also own
Based on the portfolios of people who own KRBP. This list is generated using Robinhood data, and it’s not a recommendation.